Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Stoxx Europe 50 846421 / EU0009658160

4’709.38 Pkt
-25.92 Pkt
-0.55 %
11:34:00

Analysen zu Stoxx Europe 50-Werten

10:09 Diageo Hold Deutsche Bank AG
09:27 Airbus Buy Jefferies & Company Inc.
08:54 AstraZeneca Buy UBS AG
08:36 Rheinmetall Buy Jefferies & Company Inc.
07:54 Diageo Outperform Bernstein Research
07:50 Novo Nordisk Overweight JP Morgan Chase & Co.
07:44 Novo Nordisk Underperform Jefferies & Company Inc.
07:23 Novo Nordisk Outperform Bernstein Research
07:14 GSK Underweight JP Morgan Chase & Co.
07:11 Rheinmetall Overweight JP Morgan Chase & Co.
07:07 Diageo Buy Jefferies & Company Inc.
06.11.25 Rheinmetall Market-Perform Bernstein Research
06.11.25 Rheinmetall Kaufen DZ BANK
06.11.25 Diageo Sector Perform RBC Capital Markets
06.11.25 Novo Nordisk Buy Goldman Sachs Group Inc.
06.11.25 Siemens Hold Deutsche Bank AG
06.11.25 AstraZeneca Buy UBS AG
06.11.25 Diageo Buy UBS AG
06.11.25 Novo Nordisk Buy Deutsche Bank AG
06.11.25 National Grid Neutral UBS AG
06.11.25 Zurich Insurance Sell UBS AG
06.11.25 ING Group Hold Deutsche Bank AG
06.11.25 Novo Nordisk Neutral UBS AG
06.11.25 Zurich Insurance Underweight JP Morgan Chase & Co.
06.11.25 National Grid Overweight JP Morgan Chase & Co.
06.11.25 Diageo Neutral JP Morgan Chase & Co.
06.11.25 Rheinmetall Overweight JP Morgan Chase & Co.
06.11.25 Rheinmetall Buy Jefferies & Company Inc.
06.11.25 Diageo Sector Perform RBC Capital Markets
06.11.25 UBS Outperform RBC Capital Markets
06.11.25 Roche Underperform Jefferies & Company Inc.
05.11.25 Unilever Underperform Jefferies & Company Inc.
05.11.25 BP Sector Perform RBC Capital Markets
05.11.25 Novo Nordisk Outperform Bernstein Research
05.11.25 Intesa Sanpaolo Neutral Goldman Sachs Group Inc.
05.11.25 Novo Nordisk Neutral UBS AG
05.11.25 Airbus Buy Deutsche Bank AG
05.11.25 Novo Nordisk Underperform Jefferies & Company Inc.
05.11.25 Novo Nordisk Overweight JP Morgan Chase & Co.
05.11.25 RELX Outperform Bernstein Research